	US 12,037,614 B2
	Lipase variants and microcapsule compositions comprising such lipase variants
Miguel Duarte Guilherme Pereira Toscano, Frederiksberg (DK); Thomas Agersten Poulsen, Ballerup (DK); Carsten Horslev Hansen, Vaerloese (DK); Lone Baunsgaard, Helsingor (DK); and Keith Gibson, Bagsvaerd (DK)
Assigned to Novozymes A/S, Bagsvaerf (DK)
Filed by Novozymes A/S, Bagsvaerd (DK)
Filed on Apr. 11, 2022, as Appl. No. 17/717,176.
Application 17/717,176 is a division of application No. 16/645,914, granted, now 11,332,725, previously published as PCT/EP2018/075852, filed on Sep. 25, 2018.
Claims priority of application No. 17193514 (EP), filed on Sep. 27, 2017; and application No. 18180386 (EP), filed on Jun. 28, 2018.
Prior Publication US 2022/0333088 A1, Oct. 20, 2022
Int. Cl. C12N 9/20 (2006.01); C11D 3/386 (2006.01)

CPC C12N 9/20 (2013.01) [C11D 3/38627 (2013.01); C11D 3/38672 (2013.01)]

23 Claims

1. A variant of a parent lipase, wherein the variant has lipase activity and has at least 90% but less than 100% sequence identity with SEQ ID NO: 2, wherein said variant comprises a substitution at positions corresponding to A40I, T231R, and N233R of SEQ ID NO: 2 and said variant has improved wash performance compared to a lipase comprising the amino acid sequence of SEQ ID NO: 2.